Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes

This study is currently recruiting participants.

Verified by National Taiwan University Hospital, April 2004

First Received: September 12, 2005 No Changes Posted

Sponsored by:	National Taiwan University Hospital
Information provided by:	National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00173030

Purpose

Multi-locus and multi-gene studies of atrial fibrillation, focusing on renin-angiotensin system genes and C reactive protein gene

Condition
Atrial Fibrillation

Study Type:	Observational
Study Design:	Cross-Sectional, Case Control, Prospective Study

Resource links provided by NLM:

MedlinePlus related topics: Atrial Fibrillation

Eligibility

Ages Eligible for Study:	20 Years to 90 Years
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00173030

Contacts

Contact: Chia-Ti Tsai, MD

886-2-23123456 ext 5761

Locations

Taiwan
National Taiwan University Hospital	Recruiting
Taipei, Taiwan
Contact: Chia-Ti Tsai

Sponsors and Collaborators

National Taiwan University Hospital

Investigators

Study Chair:

Jiunn-Lee Lin

National Taiwan University Hospital

More Information

No publications provided

Study ID Numbers:	9361700499
Study First Received:	September 12, 2005
Last Updated:	September 12, 2005
ClinicalTrials.gov Identifier:	NCT00173030 History of Changes
Health Authority:	Taiwan: Department of Health

Study placed in the following topic categories:

Heart Diseases
Atrial Fibrillation
Arrhythmias, Cardiac

Additional relevant MeSH terms:

Pathologic Processes
Heart Diseases
Cardiovascular Diseases
Atrial Fibrillation
Arrhythmias, Cardiac

ClinicalTrials.gov processed this record on September 10, 2009